| LINE ITEM (USD / %) | FY 2025
FILED 2025-06-30 | FY 2024
FILED 2024-06-30 | FY 2023
FILED 2023-06-30 |
|---|---|---|---|
| Revenue (Total Sales) | $5.17B | $5.77B | $4.48B |
| YoY Revenue Growth % | -10.4% | +28.6% | — |
| Gross Profit | $3.73B | $4.19B | — |
| Gross Margin % | 72.3% | 72.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $892.7M | $887.1M | $516.3M |
| Operating Margin % | 17.3% | 15.4% | 11.5% |
| Net Income (GAAP) | $435.9M | $465.1M | $150.4M |
| EBITDA (Normalized) | $1.08B | $1.09B | $677.8M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $830.6M | $967.7M | $779.2M |
| Capital Expenditures (CapEx) | $232.6M | $259.6M | $201.8M |
| Free Cash Flow (FCF) | $598.0M | $708.1M | $577.4M |
| FCF Margin % | 11.6% | 12.3% | 12.9% |
| Return on Invested Capital (ROIC %) | 7.7% | 7.4% | 12.5% |
| Cash & Short-Term Equivalents | $1.27B | $1.12B | — |
| Total Debt (Short + Long Term) | $6.34B | $6.35B | $1.26B |
| Total Stockholders' Equity | $4.04B | $4.23B | $2.58B |